Icon, a CRO based in Dublin, has acquired MolecularMD, a molecular diagnostic specialty lab that focuses on a platform for the development and commercialization of precision medicines for oncology.
ICON plc has announced the acquisition of MolecularMD for an undisclosed sum. MolecularMD has developed a portfolio of oncology-focused molecular diagnostic services. With the deal, ICON gains the ...
After national search, Strafel receives unanimous endorsement for top role at the rapidly growing health sciences company VANCOUVER, Wash., July 21, 2022 /PRNewswire/ -- Today, Molecular Testing Labs, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback